Researchers have successfully identified two genetic markers for potentially effective treatment of Mesothelioma, an orphan disease most commonly associated with asbestos exposure, and for which few treatments exist.
4-Feb-2019 11:45 AM EST Add to Favorites
A study finds that palbociclib, in combination with endocrine therapy, improves progression free survival
11-Dec-2018 7:55 AM EST Add to Favorites
SHRO Partners with Film Festival to Recognize Importance of Virtual Reality in Medicine and Celebrate Italian-Origin Filmmakers
This week, SHRO partners with the Italian Movie Award International Film Festival to support Italian-American work in cinema, particularly in recognition for accomplishments with the use of Virtual Reality (VR) in applications in medicine
10-Dec-2018 2:05 PM EST Add to Favorites
Italian-American Foundation Honors Antonio Giordano, MD, PhD Founder & President of Sbarro Health Research Organization
Italian-American Foundation, Filitalia, honors Antonio Giordano, MD, PhD, Founder & President of Sbarro Health Research Organization at Temple University with the Humanitarian award at the foundation’s 31st Anniversary Gala.
12-Nov-2018 9:00 AM EST Add to Favorites
Dompé at the medical conference “The Impact of Environment and Healthy Lifestyles in Human Health” - October 13th, Washington, D.C
Sbarro Health Research Organization, on the occasion of the medical conference “The impact of environment and healthy lifestyles in human health,” honoured Nathalie Dompé, CEO Dompé Holdings, with a special Award for Societal Impact in...
13-Oct-2018 2:00 PM EDT Add to Favorites
The medical conference is organized by the Sbarro Health Research Organization (SHRO), in collaboration with Temple University’s College of Science and Technology, the National Italian American Foundation (NIAF), and the Giovan Giacomo Giordano...
3-Oct-2018 9:00 AM EDT Add to Favorites
Healthier Planet, Healthier People, and More Innovative Medical Science with Italian-American Researchers at Annual NIAF Convention
Foundation Awards Presented for Ethics and Creativity in Medical Research, and Societal Impact in Business & Biotechnology
2-Oct-2018 9:00 AM EDT Add to Favorites
Inhibition of miR-24-3p reduced growth of cancer cells and was found to regulate proteins as a potential treatment target for Mesothelioma (MPM). The new potential target, and the method researchers have used to identify it, is an important step in...
24-Aug-2018 1:45 PM EDT Add to Favorites
see all news
6-Jun-2018 11:35 AM EDT
16-Jan-2018 11:05 AM EST
Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT
“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST